Literature DB >> 25203679

Acute toxicity studies of a novel excipient arabinoxylan isolated from Ispaghula (Plantago ovata) husk.

Alia Erum1, Sajid Bashir, Shazia Saghir, Ume Ruqia Tulain, Uzma Saleem, Muhammad Nasir, Farina Kanwal, Muhammad Nasir Hayat Malik.   

Abstract

PURPOSE: The arabinoxylan from Ispaghula (Plantago ovata) husk has been proven scientifically as potential excipient. However, toxicity study of the arabinoxylan is still lacking. The present study was done to investigate the acute toxicity of arabinoxylan in two animal species.
METHODS: The mice were exposed to (1 g/kg, 5 g/kg, 10 g/kg) and rabbits (2.5 g/kg, 5 g/kg) of arabinoxylan orally and observed for a period of 14 days. On day 15 hematology, serum biochemistry and necropsy was performed in mice relative organ weight calculated and histological examination was carried out. Primary dermal and eye irritation tests were carried out. Cardiac effects of isolated arabinoxylan were studied on frog heart.
RESULTS: The acute administration of the arabinoxylan did not produce mortality or significant changes in, water and food consumption however body weights of mice and rabbits decreased initially with a gradual increase till day 14. Internal organs relative weights were found to be normal. Hematological biochemical and histopathological examination did not show any significant (p < 0.05) change. Primary dermal and eye irritation was not observed in treated rabbits. No change in heart rate and vascular contraction was observed in frog heart.
CONCLUSION: This study has shown that acute administration of arabinoxylan may be safe.

Entities:  

Keywords:  Excipient; Ispaghula husk; toxicity testing

Mesh:

Substances:

Year:  2014        PMID: 25203679     DOI: 10.3109/01480545.2014.956219

Source DB:  PubMed          Journal:  Drug Chem Toxicol        ISSN: 0148-0545            Impact factor:   3.356


  5 in total

1.  Ethnopharmacological survey of medicinal plants practiced by traditional healers and herbalists for treatment of some urological diseases in the West Bank/Palestine.

Authors:  Nidal Amin Jaradat; Abdel Naser Zaid; Rowa Al-Ramahi; Malik A Alqub; Fatima Hussein; Zakaria Hamdan; Mahmoud Mustafa; Mohammad Qneibi; Iyad Ali
Journal:  BMC Complement Altern Med       Date:  2017-05-08       Impact factor: 3.659

2.  Development of Tizanidine HCl-Meloxicam loaded mucoadhesive buccal films: In-vitro and in-vivo evaluation.

Authors:  Muhammad Zaman; Muhammad Hanif; Zaib Ali Shaheryar
Journal:  PLoS One       Date:  2018-03-22       Impact factor: 3.240

3.  The Development of Eletriptan Hydrobromide Immediate Release Buccal Films Using Central Composite Rotatable Design: An In Vivo and In Vitro Approach.

Authors:  Waqar Siddique; Muhammad Zaman; Rai Muhammad Sarfraz; Muhammad Hammad Butt; Atta Ur Rehman; Noman Fassih; Ghadeer M Albadrani; Roula Bayram; Mohammad Y Alfaifi; Mohamed M Abdel-Daim
Journal:  Polymers (Basel)       Date:  2022-09-23       Impact factor: 4.967

4.  Synthesis and Evaluation of Thiol-Conjugated Poloxamer and Its Pharmaceutical Applications.

Authors:  Muhammad Zaman; Sadaf Saeed; Rabia Imtiaz Bajwa; Muhammad Shafeeq Ur Rahman; Saeed Ur Rahman; Muhammad Jamshaid; Muhammad F Rasool; Abdul Majeed; Imran Imran; Faleh Alqahtani; Sultan Alshehri; Abdullah F AlAsmari; Nemat Ali; Mohammed Alasmari
Journal:  Pharmaceutics       Date:  2021-05-11       Impact factor: 6.321

5.  β-cyclodextrin chitosan-based hydrogels with tunable pH-responsive properties for controlled release of acyclovir: design, characterization, safety, and pharmacokinetic evaluation.

Authors:  Nadia Shamshad Malik; Mahmood Ahmad; Mohammed S Alqahtani; Arshad Mahmood; Kashif Barkat; Muhammad Tariq Khan; Ume Ruqia Tulain; Ayesha Rashid
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.819

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.